FPN || Respiratory and Sleep Medicine

FDA panel backs approval of inhaled insulin for type 1 and 2 diabetes

Posted on: 02/04/2014 - 17:40

HYATTSVILLE, MD. – Inhaled insulin will probably become available as a treatment option again, with a Food and Drug Administration advisory panel’s recommendation to approve an orally administered...

Field of Interest: Endocrinology

Type: News Item

Tuberculosis rate drops, disparity continues

Posted on: 21/03/2014 - 20:20

Despite the overall decline in tuberculosis, there continues to be a large disparity in incidence between U.S.-born and foreign-born U.S. residents, the Centers for Disease Control and Prevention...

Field of Interest: Infectious diseases

Type: News Item

Chronic rhinosinusitis with nasal polyps more severe in women

Posted on: 03/03/2014 - 16:15

SAN DIEGO – Women with chronic rhinosinusitis and co-occurring nasal polyps appear to harbor more severe disease, compared with men, results from a large retrospective study demonstrate. "For...

Field of Interest: Pulmonology

Type: News Item

CPAP improves resistant hypertension in patients with obstructive sleep apnea

Posted on: 10/12/2013 - 21:00

For patients who have resistant hypertension and obstructive sleep apnea, 3 months of treatment with continuous positive airway pressure significantly reduces mean and diastolic blood pressure and...

Field of Interest: Cardiology

Type: News Item

Smoking cessation agents don’t raise serious CVD risks

Posted on: 09/12/2013 - 21:00

The three smoking cessation agents bupropion, varenicline, and nicotine replacement therapy did not raise the risk of serious adverse cardiovascular events in a network meta-analysis of 63 randomized...

Field of Interest: Cardiology

Type: News Item

Newsletters

Stay informed on our latest news!

You are here

FDA panel backs approval of inhaled insulin for type 1 and 2 diabetes

Tuberculosis rate drops, disparity continues

Chronic rhinosinusitis with nasal polyps more severe in women

CPAP improves resistant hypertension in patients with obstructive sleep apnea

Smoking cessation agents don’t raise serious CVD risks

Newsletters

Latest Newsletters